For example, SLE and RA patients were found to have high levels of IFN-γ for a few years before being diagnosed [61,62], while MS patients exhibited increased IFN-γ in blood samples and IFN-γ-induced chemokines in lesions [63]. The gene discussed is IFNG; the disease is myeloid sarcoma.